Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) — Working Capital to Net Assets Ratio
Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a Working Capital to Net Assets ratio of 25.5% as of March 2026. Working capital of NT$809.48 Million (current assets of NT$1.21 Billion minus current liabilities of NT$401.64 Million) is measured against net assets of NT$3.18 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Chunghwa Chemical Synthesis & Biotech Co defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Chunghwa Chemical Synthesis & Biotech Co Ltd Working Capital to Net Assets (2009–2025)
This chart shows how Chunghwa Chemical Synthesis & Biotech Co Ltd's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of March 2026, the ratio stands at 25.5%, reflecting working capital of NT$809.48 Million against net assets of NT$3.18 Billion TWD. For the complete balance sheet picture, see Chunghwa Chemical Synthesis & Biotech Co total assets.
Annual Working Capital to Net Assets for Chunghwa Chemical Synthesis & Biotech Co Ltd (2009–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Chunghwa Chemical Synthesis & Biotech Co Ltd from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Chunghwa Chemical Synthesis & Biotech Co to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 22.7% | NT$702.18 Million | NT$3.09 Billion | NT$1.06 Billion | NT$356.71 Million | ▼ -7.5 pp |
| 2024 | 30.3% | NT$1.02 Billion | NT$3.36 Billion | NT$1.44 Billion | NT$425.29 Million | ▲ +1.7 pp |
| 2023 | 28.5% | NT$956.37 Million | NT$3.35 Billion | NT$1.79 Billion | NT$831.41 Million | ▲ +2.4 pp |
| 2022 | 26.1% | NT$834.81 Million | NT$3.19 Billion | NT$1.45 Billion | NT$614.18 Million | ▲ +1.2 pp |
| 2021 | 24.9% | NT$721.91 Million | NT$2.89 Billion | NT$1.36 Billion | NT$635.17 Million | ▲ +0.9 pp |
| 2020 | 24.1% | NT$601.44 Million | NT$2.50 Billion | NT$1.00 Billion | NT$400.16 Million | ▲ +18.6 pp |
| 2019 | 5.5% | NT$111.16 Million | NT$2.02 Billion | NT$687.58 Million | NT$576.42 Million | ▼ -4.0 pp |
| 2018 | 9.5% | NT$188.10 Million | NT$1.98 Billion | NT$613.79 Million | NT$425.69 Million | ▼ -2.5 pp |
| 2017 | 12.0% | NT$218.81 Million | NT$1.82 Billion | NT$1.03 Billion | NT$808.31 Million | ▲ +5.4 pp |
| 2016 | 6.6% | NT$117.21 Million | NT$1.77 Billion | NT$728.77 Million | NT$611.56 Million | ▼ -5.7 pp |
| 2015 | 12.3% | NT$229.39 Million | NT$1.86 Billion | NT$864.49 Million | NT$635.10 Million | ▼ -21.2 pp |
| 2014 | 33.5% | NT$540.90 Million | NT$1.62 Billion | NT$1.24 Billion | NT$696.09 Million | ▲ +25.5 pp |
| 2013 | 8.0% | NT$136.23 Million | NT$1.71 Billion | NT$667.37 Million | NT$531.14 Million | ▲ +1.8 pp |
| 2012 | 6.1% | NT$103.00 Million | NT$1.68 Billion | NT$679.33 Million | NT$576.33 Million | ▼ -13.1 pp |
| 2011 | 19.3% | NT$323.45 Million | NT$1.68 Billion | NT$768.55 Million | NT$445.10 Million | ▼ -1.0 pp |
| 2010 | 20.3% | NT$341.83 Million | NT$1.68 Billion | NT$758.58 Million | NT$416.75 Million | ▲ +14.7 pp |
| 2009 | 5.6% | NT$67.31 Million | NT$1.19 Billion | NT$655.85 Million | NT$588.54 Million | — |